logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hiroyuki Marusawa

osaka red cross hospital
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study

仑伐替尼与阿替利珠单抗联合贝伐珠单抗作为CRAFITY评分为2分的晚期肝细胞癌的一线治疗：一项多中心回顾性研究

Hepatology Research
IF3.4
2025-09-130
PRE
Masayuki Ueno; Haruhiko Takeda; Atsushi Takai; Makoto Umeda; Hiroki Morimura; Shunsuke Okuyama; Norihiro Nishijima; Satoru Iwamoto; Shigeharu Nakano; Shu Nagatomo; Takeshi Seta; Tomoyuki Goto; Atsuyuki Ikeda; Takahisa Kayahara; Shin'ichi Miyamoto; Shujiro Yazumi; Taro Ueo; Yoshito Uenoyama; Kazuyoshi Matsumura; Masako Mishima; Tadashi Inuzuka; Yuji Eso; Ken Takahashi; Hiroyuki Marusawa; Yukio Osaki; Etsuro Hatano; Hiroshi Seno
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study (oct, 10.1007/s00535-024-02150-7, 2024)
JOURNAL OF GASTROENTEROLOGY
IF5.5
2024-10-210
OAAI
Ueno, Masayuki; Takeda, Haruhiko; Takai, Atsushi; Morimura, Hiroki; Nishijima, Norihiro; Iwamoto, Satoru; Okuyama, Shunsuke; Umeda, Makoto; Seta, Takeshi; Ikeda, Atsuyuki; Goto, Tomoyuki; Miyamoto, Shin'ichi; Kayahara, Takahisa; Uenoyama, Yoshito; Matsumura, Kazuyoshi; Nakano, Shigeharu; Mishima, Masako; Inuzuka, Tadashi; Eso, Yuji; Takahashi, Ken; Marusawa, Hiroyuki; Osaki, Yukio; Hatano, Etsuro; Seno, Hiroshi
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study
JOURNAL OF GASTROENTEROLOGY
IF5.5
2024-09-182
OAAI
Ueno, Masayuki; Takeda, Haruhiko; Takai, Atsushi; Morimura, Hiroki; Nishijima, Norihiro; Iwamoto, Satoru; Okuyama, Shunsuke; Umeda, Makoto; Seta, Takeshi; Ikeda, Atsuyuki; Goto, Tomoyuki; Miyamoto, Shin'ichi; Kayahara, Takahisa; Uenoyama, Yoshito; Matsumura, Kazuyoshi; Nakano, Shigeharu; Mishima, Masako; Inuzuka, Tadashi; Eso, Yuji; Takahashi, Ken; Marusawa, Hiroyuki; Osaki, Yukio; Hatano, Etsuro; Seno, Hiroshi
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapy
LIVER INTERNATIONAL
IF5.2
2024-09-021
PRE
Tada, Toshifumi; Kurosaki, Masayuki; Toyoda, Hidenori; Tamaki, Nobuharu; Yasui, Yutaka; Nakamura, Shinichiro; Mori, Nami; Tsuji, Keiji; Ochi, Hironori; Akahane, Takehiro; Kobashi, Haruhiko; Fujii, Hideki; Marusawa, Hiroyuki; Kondo, Masahiko; Urawa, Naohito; Yoshida, Hideo; Uchida, Yasushi; Morita, Atsuhiro; Hasebe, Chitomi; Mitsuda, Akeri; Ogawa, Chikara; Narita, Ryoichi; Kubotsu, Yoshihito; Matsushita, Tomomichi; Shigeno, Masaya; Okamoto, Eisuke; Okada, Kazuhiko; Kasai, Toyotaka; Ishii, Toru; Nonogi, Michiko; Yasuda, Satoshi; Koshiyama, Yuichi; Kumada, Takashi; Izumi, Namiki
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma

在不可切除的肝细胞癌中，先前使用免疫检查点抑制剂进展后对durvalumab联合tremelimumab的治疗反应

INVESTIGATIONAL NEW DRUGS
IF2.7
2024-08-303
PRE
Mori, Nami; Tamaki, Nobuharu; Takaki, Shintaro; Tsuji, Keiji; Tada, Toshifumi; Nakamura, Shinichiro; Ochi, Hironori; Mashiba, Toshie; Doisaki, Masao; Marusawa, Hiroyuki; Kobashi, Haruhiko; Fujii, Hideki; Ogawa, Chikara; Nonogi, Michiko; Arai, Hirotaka; Uchida, Yasushi; Urawa, Naohito; Narita, Ryoichi; Akahane, Takehiro; Kondo, Masahiko; Yasui, Yutaka; Tsuchiya, Kaoru; Izumi, Namiki; Kurosaki, Masayuki
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning
BRITISH JOURNAL OF CANCER
IF6.8
2024-08-283
OA
Kawai, Munenori; Fukuda, Akihisa; Otomo, Ryo; Obata, Shunsuke; Minaga, Kosuke; Asada, Masanori; Umemura, Atsushi; Uenoyama, Yoshito; Hieda, Nobuhiro; Morita, Toshihiro; Minami, Ryuki; Marui, Saiko; Yamauchi, Yuki; Nakai, Yoshitaka; Takada, Yutaka; Ikuta, Kozo; Yoshioka, Takuto; Mizukoshi, Kenta; Iwane, Kosuke; Yamakawa, Go; Namikawa, Mio; Sono, Makoto; Nagao, Munemasa; Maruno, Takahisa; Nakanishi, Yuki; Hirai, Mitsuharu; Kanda, Naoki; Shio, Seiji; Itani, Toshinao; Fujii, Shigehiko; Kimura, Toshiyuki; Matsumura, Kazuyoshi; Ohana, Masaya; Yazumi, Shujiro; Kawanami, Chiharu; Yamashita, Yukitaka; Marusawa, Hiroyuki; Watanabe, Tomohiro; Ito, Yoshito; Kudo, Masatoshi; Seno, Hiroshi
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
INVESTIGATIONAL NEW DRUGS
IF2.7
2023-03-3011
PRE
Takaki, Shintaro; Kurosaki, Masayuki; Mori, Nami; Tsuji, Keiji; Ochi, Hironori; Marusawa, Hiroyuki; Nakamura, Shinichiro; Tada, Toshifumi; Narita, Ryoichi; Uchida, Yasushi; Akahane, Takehiro; Kondo, Masahiko; Kusakabe, Atsunori; Furuta, Koichiro; Kobashi, Haruhiko; Arai, Hirotaka; Nonogi, Michiko; Tamada, Takashi; Hasebe, Chitomi; Ogawa, Chikara; Sato, Takashi; Tamaki, Nobuharu; Yasui, Yutaka; Tsuchiya, Kaoru; Izumi, Namiki
Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis

DNA甲基转移酶3B的S-亚硝基化在肿瘤发生的表观遗传调控中的关键作用

NATURE COMMUNICATIONS
IF15.7
2023-02-0410
OAAI
Okuda, Kosaku; Nakahara, Kengo; Ito, Akihiro; Iijima, Yuta; Nomura, Ryosuke; Kumar, Ashutosh; Fujikawa, Kana; Adachi, Kazuya; Shimada, Yuki; Fujio, Satoshi; Yamamoto, Reina; Takasugi, Nobumasa; Onuma, Kunishige; Osaki, Mitsuhiko; Okada, Futoshi; Ukegawa, Taichi; Takeuchi, Yasuo; Yasui, Norihisa; Yamashita, Atsuko; Marusawa, Hiroyuki; Matsushita, Yosuke; Katagiri, Toyomasa; Shibata, Takahiro; Uchida, Koji; Niu, Sheng-Yong; Lang, Nhi B.; Nakamura, Tomohiro; Zhang, Kam Y. J.; Lipton, Stuart A.; Uehara, Takashi
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
JOURNAL OF MEDICAL VIROLOGY
IF4.6
2022-10-204
PRE
Kaneko, Shun; Kurosaki, Masayuki; Mashiba, Toshie; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Uchida, Yasushi; Fujii, Hideki; Akahane, Takehiro; Yagisawa, Hitoshi; Kusakabe, Atsunori; Kobashi, Haruhiko; Abe, Takehiko; Yoshida, Hideo; Ogawa, Chikara; Furuta, Koichiro; Tamaki, Nobuharu; Tsuji, Keiji; Matsushita, Tomomichi; Izumi, Namiki
Usefulness of neutrophil-to-lymphocyte ratio in predicting progression and survival outcomes after atezolizumab-bevacizumab treatment for hepatocellular carcinoma
HEPATOLOGY RESEARCH
IF3.4
2022-10-0432
OAAI
Ochi, Hironori; Kurosaki, Masayuki; Joko, Kouji; Mashiba, Toshie; Tamaki, Nobuharu; Tsuchiya, Kaoru; Marusawa, Hiroyuki; Tada, Toshifumi; Nakamura, Shinichiro; Narita, Ryoichi; Uchida, Yasushi; Akahane, Takehiro; Kondo, Masahiko; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kusakabe, Atsunori; Furuta, Koichiro; Kobashi, Haruhiko; Arai, Hirotaka; Nonogi, Michiko; Tamada, Takashi; Hasebe, Chitomi; Izumi, Namiki
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
INVESTIGATIONAL NEW DRUGS
IF2.7
2022-09-2412
PRE
Tamaki, Nobuharu; Tada, Toshifumi; Kurosaki, Masayuki; Yasui, Yutaka; Ochi, Hironori; Mashiba, Toshie; Sakamoto, Azusa; Marusawa, Hiroyuki; Narita, Ryoichi; Uchida, Yasushi; Akahane, Takehiro; Kondo, Masahiko; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kobashi, Haruhiko; Kusakabe, Atsunori; Furuta, Koichiro; Arai, Hirotaka; Nonogi, Michiko; Ogawa, Chikara; Sato, Takashi; Tamada, Takashi; Nakamura, Shinichiro; Hasebe, Chitomi; Tsuchiya, Kaoru; Izumi, Namiki

研究方向

暂未获取到该数据
T
Tsutomu Chiba
H 指数:92论文数:1,430被引数:3.7万
Y
Yoshihide Ueda
H 指数:31论文数:226被引数:6,219
A
Atsushi Takai
H 指数:25论文数:98被引数:2,101
Y
Yuji Eso
H 指数:20论文数:164被引数:1,268
H
Hiroshi Seno
H 指数:53论文数:756被引数:1.2万
S
Shinji Üemoto
H 指数:96论文数:1,523被引数:3.8万
T
Takahiro Shimizu
H 指数:18论文数:117被引数:1,200
H
Haruhiko Takeda
H 指数:25论文数:124被引数:1,771
T
Tadashi Inuzuka
H 指数:17论文数:87被引数:847
M
Masayuki Kurosaki
H 指数:60论文数:696被引数:1.6万